相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Taking a Bite out of Malaria: Controlled Human Malaria Infection by Needle and Syringe
Judith E. Epstein
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2013)
NF135.C10: A New Plasmodium falciparum Clone for Controlled Human Malaria Infections
Anne C. Teirlinck et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Review: Controlled Human Blood Stage Malaria Infection: Current Status and Potential Applications
Christopher J. A. Duncan et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2012)
Human microbial challenge: the ultimate animal model
Andrew J. Pollard et al.
LANCET INFECTIOUS DISEASES (2012)
A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants
Sara Mian-McCarthy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
A consultation on the optimization of controlled human malaria infection by mosquito bite for evaluation of candidate malaria vaccines
Matthew B. Laurens et al.
VACCINE (2012)
The RTS,S vaccine candidate for malaria
Jason A. Regules et al.
EXPERT REVIEW OF VACCINES (2011)
A Pilot Randomised Trial of Induced Blood-Stage Plasmodium falciparum Infections in Healthy Volunteers for Testing Efficacy of New Antimalarial Drugs
James S. McCarthy et al.
PLOS ONE (2011)
Experimental human challenge infections can accelerate clinical malaria vaccine development
Robert W. Sauerwein et al.
NATURE REVIEWS IMMUNOLOGY (2011)
From the circumsporozoite protein to the RTS, S/AS candidate vaccine
Joe Cohen et al.
HUMAN VACCINES (2010)
Case Report: Successful Sporozoite Challenge Model in Human Volunteers with Plasmodium vivax Strain Derived from Human Donors
Socrates Herrera et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2009)
Randomized, Double-Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria-Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection
Kent E. Kester et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Phase 1/2a Study of the Malaria Vaccine Candidate Apical Membrane Antigen-1 (AMA-1) Administered in Adjuvant System AS01B or AS02A
Michele D. Spring et al.
PLOS ONE (2009)
Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area
Mark E. Polhemus et al.
PLOS ONE (2009)
Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naive adults at the Walter Reed Army Institute of Research
Kent E. Kester et al.
VACCINE (2008)
A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naive adults
Kent E. Kester et al.
VACCINE (2007)
A DNA prime-modified vaccinia virus Ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge
S. J. Dunachie et al.
INFECTION AND IMMUNITY (2006)
A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults
VS Moorthy et al.
PLOS MEDICINE (2004)
Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children:: randomised controlled trial
PL Alonso et al.
LANCET (2004)
Safety and immunogenicity of a three-component blood-stage malaria vaccine (MSP1, MSP2, RESA) against Plasmodium falciparum in Papua New Guinean children
B Genton et al.
VACCINE (2003)
Efficacy of RTS,S/ASO2 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia:: a randomised trial
KA Bojang et al.
LANCET (2001)
Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria
KE Kester et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Effect of vaccination with 3 recombinant asexual-stage malaria antigens on initial growth rates of Plasmodium falciparum in non-immune volunteers
G Lawrence et al.
VACCINE (2000)
分享论文
